secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001104659-23-100115
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin grants exclusive license for QRX003 in Singapore to Farma Mondo
---------------------------------------------------------------------

- Exclusive license to Farma Mondo SA to commercialize QRX003 in Singapore.
- Licensee must file for regulatory approvals within 6 months of Quoin's FDA/EMA approval.
- Financial terms not disclosed; royalties payable to Quoin.
- Parties to negotiate supply agreement for product manufacture and supply.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465923100115/0001104659-23-100115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465923100115/tm2325985d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-100115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer